[{"orgOrder":0,"company":"Pharmanza Herbal","sponsor":"NovoBliss Research","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2026","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Pharmanza Herbal","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Pharmanza Herbal \/ Pharmanza Herbal","highestDevelopmentStatusID":"1","companyTruncated":"Pharmanza Herbal \/ Pharmanza Herbal"}]

Find Clinical Drug Pipeline Developments & Deals by Pharmanza Herbal

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          VMX
                          Not Confirmed
                          VMX
                          Not Confirmed

                          Details : Saffron Extract is a Plant Extract/Herbal drug, which is currently being evaluated in clinical studies for the treatment of Skin Aging.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          January 07, 2026

                          Lead Product(s) : Saffron Extract

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Recipient : NovoBliss Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank